Atlas Trials

Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

Clinical trial NCT03654937 · COMPLETED

Trial details

NCT number
NCT03654937
Sponsor
Universität des Saarlandes
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza Virus Vaccine Adverse ReactionInfluenza Vaccine Allergy
Start date
2016-09-01
Primary completion
2016-12-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.